Beam Aktie
WKN DE: A1JKNP / ISIN: US0737301038
06.05.2025 13:13:49
|
Beam Therapeutics Inc. Q1 Loss Increases, Misses Estimates
(RTTNews) - Beam Therapeutics Inc. (BEAM) reported Loss for its first quarter that increased from last year and missed the Street estimates.
The company's bottom line totaled -$109.27 million, or -$1.24 per share. This compares with -$98.67 million, or -$1.21 per share, last year.
Analysts on average had expected the company to earn -$1.17 per share. Analysts' estimates typically exclude special items.
Beam Therapeutics Inc. earnings at a glance (GAAP) :
-Earnings: -$109.27 Mln. vs. -$98.67 Mln. last year. -EPS: -$1.24 vs. -$1.21 last year.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Beam Inc Cash Settlement At USD 83.50 A Shmehr Nachrichten
Keine Nachrichten verfügbar. |